Advaxis Appoints Christopher Duke as Chief Operating Officer
Oct 03, 2016 12:00 pm UTC| Business
Greg Mayes Becomes Company’s First Chief Business Officer Advaxis Appoints...
ACACIA DIVERSIFIED HOLDINGS, INC. (OTCQB:ACCA) ANNOUNCES U.S. ORGANIC CERTIFICATION
Oct 03, 2016 12:00 pm UTC| Business
Clearwater, FL, Oct. 03, 2016 -- Acacia Diversified Holdings, Inc. (OTCQB:ACCA) (the “Company”) today announced that its wholly-owned subsidiary, MariJ Pharmaceuticals, Inc. (“MariJ”), has received an Organic...
Oct 03, 2016 12:00 pm UTC| Business
VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 03, 2016 -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced a partnership...
Cara Therapeutics to Participate in Webcast on Pain Targeting Mechanisms
Oct 03, 2016 12:00 pm UTC| Business
Webcast to be held Thursday, October 6, 2016 at 11:00 a.m. ET STAMFORD, Conn., Oct. 03, 2016 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical...
Oct 03, 2016 12:00 pm UTC| Business
VERO BEACH, Florida, Oct. 03, 2016 -- ARMOUR Residential REIT, Inc. (NYSE: ARR, ARR PrA and ARR PrB) (“ARMOUR” or the “Company”) today confirmed the October 2016 cash dividend rate for the Company’s Common Stock and the...
Oct 03, 2016 12:00 pm UTC| Business
EFFINGHAM, Ill., Oct. 03, 2016 -- Midland States Bancorp, Inc. (NASDAQ:MSBI) announced today that it will issue its third quarter 2016 financial results after market close on Thursday, October 27, 2016. Midland States...
Albireo Announces Positive Top-Line Phase 3 Results for Elobixibat in Japan
Oct 03, 2016 12:00 pm UTC| Business
BOSTON, Oct. 03, 2016 -- Albireo Limited announced today positive top-line results from a pivotal Phase 3 clinical trial of its product candidate, elobixibat, in chronic constipation conducted in Japan. In the trial,...